{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:59:33Z","timestamp":1783605573200,"version":"3.55.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005604","name":"Universidad de Huelva","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005604","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.atherosclerosis.2026.120650","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T13:47:20Z","timestamp":1776779240000},"page":"120650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Risk factors for atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolemia: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"415","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9283-9572","authenticated-orcid":false,"given":"Mar\u00eda Elena","family":"Mansilla-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"S\u00e1nchez-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina Rigabert","family":"S\u00e1nchez-Junco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Nadiejda","family":"Guti\u00e9rrez-Cortizo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Mata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel Jes\u00fas","family":"Romero-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120650_bib1","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41569-019-0325-8","article-title":"Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care","volume":"17","author":"Watts","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"22","key":"10.1016\/j.atherosclerosis.2026.120650_bib2","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.119.044795","article-title":"Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis","volume":"141","author":"Hu","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120650_bib3","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MOL.0000000000000903","article-title":"Predictors of cardiovascular risk in familial hypercholesterolemia","volume":"34","author":"Romero-Jim\u00e9nez","year":"2023","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120650_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41569-018-0052-6","article-title":"The complex molecular genetics of familial hypercholesterolaemia","volume":"16","author":"Berberich","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120650_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.atherosclerosis.2019.11.028","article-title":"Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies","volume":"293","author":"Wald","year":"2020","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120650_bib6","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jacl.2020.04.011","article-title":"Genetic testing in dyslipidemia: a scientific statement from the National Lipid Association","volume":"14","author":"Brown","year":"2020","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120650_bib7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jacl.2017.01.002","article-title":"Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia","volume":"11","author":"L\u00e1zaro","year":"2017","journal-title":"J Clin Lipidol"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120650_bib8","first-page":"1553","article-title":"Canadian cardiovascular Society position statement on familial hypercholesterolemia: update 2018","volume":"34","author":"Brunham","year":"2018","journal-title":"Can J Cardiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120650_bib9","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.hlc.2020.09.943","article-title":"Integrated guidance for enhancing the care of familial hypercholesterolaemia in Australia","volume":"30","author":"Watts","year":"2021","journal-title":"Heart Lung Circ"},{"issue":"6 June","key":"10.1016\/j.atherosclerosis.2026.120650_bib10","first-page":"1","article-title":"Comparative study on the performance of different classification algorithms, combined with pre- and post-processing techniques to handle imbalanced data, in the diagnosis of adult patients with familial hypercholesterolemia","volume":"17","author":"Albuquerque","year":"2022","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120650_bib11","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2337\/dc05-2530","article-title":"Metabolic syndrome and risk of coronary, cerebral, and peripheral vascular disease in a large Dutch population with familial hypercholesterolemia","volume":"29","author":"Rana","year":"2006","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120650_bib12","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.clinthera.2016.05.006","article-title":"Cardiovascular disease risk associated with familial hypercholesterolemia: a systematic review of the literature","volume":"38","author":"Wong","year":"2016","journal-title":"Clin Ther"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120650_bib13","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1210\/jc.2017-02622","article-title":"A comparative analysis of phenotypic predictors of mutations in familial hypercholesterolemia","volume":"103","author":"Chan","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120650_bib14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/MOL.0000000000000553","article-title":"Atherosclerotic cardiovascular disease risk assessment in familial hypercholesterolemia: does one size fit all?","volume":"29","author":"Mata","year":"2018","journal-title":"Curr Opin Lipidol"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120650_bib15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S2213-8587(24)00192-X","article-title":"Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study","volume":"12","author":"P\u00e9rez de Isla","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120650_bib16","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S2213-8587(16)30041-9","article-title":"Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel","volume":"4","author":"Santos","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120650_bib17","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1161\/ATVBAHA.116.307514","article-title":"Coronary heart disease, peripheral arterial disease, and stroke in familial hypercholesterolaemia ; insights from the SAFEHEART registry (Spanish familial hypercholesterolaemia cohort Study)","volume":"36","author":"P\u00e9rez de Isla","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120650_bib18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jacc.2019.05.043","article-title":"Risk of premature atherosclerotic disease in patients with monogenic versus polygenic familial hypercholesterolemia","volume":"74","author":"Trinder","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120650_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/qjmed\/hcz327","article-title":"The characteristics of patients with possible familial hypercholesterolemia - screening a large payer\/provider healthcare delivery system","volume":"113","author":"Elis","year":"2020","journal-title":"QJM An Int J Med"},{"issue":"22","key":"10.1016\/j.atherosclerosis.2026.120650_bib20","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1161\/CIRCULATIONAHA.116.024541","article-title":"Predicting cardiovascular events in familial hypercholesterolemia: the SAFEHEART registry (Spanish familial hypercholesterolemia cohort Study)","volume":"135","author":"P\u00e9rez de Isla","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2026.120650_bib21","first-page":"1","article-title":"External validation of the SAFEHEART risk equation for predicting cardiovascular events in Australian patients with familial hypercholesterolaemia","volume":"00","author":"Mansilla-Rodr\u00edguez","year":"2025","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120650_bib22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jacl.2016.10.004","article-title":"The Montreal-FH-SCORE: a new score to predict cardiovascular events in familial hypercholesterolemia","volume":"11","author":"Paquette","year":"2017","journal-title":"J Clin Lipidol"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120650_bib23","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1161\/ATVBAHA.121.316106","article-title":"Familial Hypercholesterolemia-Risk-Score: a new Score predicting cardiovascular events and cardiovascular mortality in familial hypercholesterolemia","volume":"41","author":"Paquette","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120650_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jacl.2018.10.012","article-title":"Risk factors for cardiovascular disease in heterozygous familial hypercholesterolemia: a systematic review and meta-analysis","volume":"13","author":"Akioyamen","year":"2019","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2026.120650_bib25","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120650_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-065551","article-title":"Risk factors for cardiovascular events in patients with heterozygous familial hypercholesterolaemia: protocol for a systematic review","volume":"13","author":"Mansilla-Rodr\u00edguez","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.atherosclerosis.2026.120650_bib27","series-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2000"},{"key":"10.1016\/j.atherosclerosis.2026.120650_bib28","series-title":"Cochrane handbook for systematic reviews of interventions version 5.1.0","author":"Higgins","year":"2011"},{"issue":"7 SE-Articles","key":"10.1016\/j.atherosclerosis.2026.120650_bib29","first-page":"1","article-title":"MetaEasy: a meta-analysis Add-In for microsoft excel","volume":"30","author":"Kontopantelis","year":"2009","journal-title":"J Stat Software"},{"key":"10.1016\/j.atherosclerosis.2026.120650_bib30","series-title":"The essential guide to effect sizes: statistical power, meta-analysis, and the interpretation of research results","author":"Ellis","year":"2010"},{"key":"10.1016\/j.atherosclerosis.2026.120650_bib31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1053\/euhj.2000.2408","article-title":"Importance of HDL cholesterol levels and the total\/HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia","volume":"22","author":"Real","year":"2001","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120650_bib32","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1161\/01.ATV.0000168909.44877.a7","article-title":"Genetic determinants of cardiovascular disease risk in familial hypercholesterolemia","volume":"25","author":"Jansen","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120650_bib33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.atherosclerosis.2007.12.024","article-title":"Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors","volume":"200","author":"Alonso","year":"2008","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120650_bib34","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1210\/jc.2008-0813","article-title":"Two common haplotypes of the glucocorticoid receptor gene are associated with increased susceptibility to cardiovascular disease in men with familial hypercholesterolemia","volume":"93","author":"Koeijvoets","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"10.1016\/j.atherosclerosis.2026.120650_bib35","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.clinbiochem.2011.11.001","article-title":"The logarithm of the triglyceride\/HDL-cholesterol ratio is related to the history of cardiovascular disease in patients with familial hypercholesterolemia","volume":"45","author":"So\u0161ka","year":"2012","journal-title":"Clin Biochem"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120650_bib36","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4161\/epi.19633","article-title":"ABCA1 gene promoter DNA methylation is associated with HDL particle profile and coronary artery disease in familial hypercholesterolemia","volume":"7","author":"Guay","year":"2012","journal-title":"Epigenetics"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120650_bib37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.atherosclerosis.2013.12.020","article-title":"Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers","volume":"233","author":"Besseling","year":"2014","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120650_bib38","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.amjcard.2014.12.034","article-title":"Assessment of Coronary atherosclerosis in patients with familial hypercholesterolemia by coronary computed tomography angiography","volume":"115","author":"Tada","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120650_bib39","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ijcard.2015.08.146","article-title":"Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia","volume":"201","author":"Chan","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120650_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2015.12.033","article-title":"Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemia","volume":"246","author":"Besseling","year":"2016","journal-title":"Atheroscler"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120650_bib41","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jacl.2016.10.004","article-title":"The Montreal-FH-SCORE: a new score to predict cardiovascular events in familial hypercholesterolemia","volume":"11","author":"Paquette","year":"2017","journal-title":"J Clin Lipidol"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120650_bib42","first-page":"1312","article-title":"Scavenger receptor LOX1 genotype predicts coronary artery disease in patients with familial hypercholesterolemia","volume":"33","author":"Paquette","year":"2017","journal-title":"Can J Cardiol"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120650_bib43","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jacl.2017.07.008","article-title":"Cardiovascular disease in familial hypercholesterolemia: validation and refinement of the Montreal-FH-SCORE","volume":"11","author":"Paquette","year":"2017","journal-title":"J Clin Lipidol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120650_bib44","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jacl.2017.03.014","article-title":"Novel protein biomarkers associated with coronary artery disease in statin-treated patients with familial hypercholesterolemia","volume":"11","author":"Bos","year":"2017","journal-title":"J Clin Lipidol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120650_bib45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2217\/pme-2017-0075","article-title":"Multivariate analysis for coronary heart disease in heterozygote familial hypercholesterolemia patients","volume":"15","author":"S\u00e1nchez Mu\u00f1oz-Torrero","year":"2018","journal-title":"Per Med"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120650_bib46","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jacl.2019.04.006","article-title":"LPA genotype is associated with premature cardiovascular disease in familial hypercholesterolemia","volume":"13","author":"Paquette","year":"2019","journal-title":"J Clin Lipidol"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120650_bib47","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.jcmg.2018.09.019","article-title":"Coronary artery calcium and cardiovascular events in patients with familial hypercholesterolemia receiving standard lipid-lowering therapy","volume":"12","author":"Miname","year":"2019","journal-title":"JACC, Cardiovasc Imaging"},{"key":"10.1016\/j.atherosclerosis.2026.120650_bib48","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.atherosclerosis.2020.07.006","article-title":"Long term follow-up of genetically confirmed patients with familial hypercholesterolemia treated with first and second-generation statins and then with PCSK9 monoclonal antibodies","volume":"308","author":"Pasta","year":"2020","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120650_bib49","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/ehjci\/jez280","article-title":"Vascular age derived from coronary artery calcium score on the risk stratification of individuals with heterozygous familial hypercholesterolaemia","volume":"21","author":"Miname","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.atherosclerosis.2026.120650_bib50","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.atherosclerosis.2020.11.012","article-title":"Coronary plaque burden, plaque characterization and their prognostic implications in familial hypercholesterolemia: a computed tomographic angiography study","volume":"317","author":"P\u00e9rez de Isla","year":"2021","journal-title":"Atherosclerosis (00219150)"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120650_bib51","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/eurheartj\/ehv563","article-title":"The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis","volume":"37","author":"Lipinski","year":"2016","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120650_bib52","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/CIRCULATIONAHA.123.064566","article-title":"Long-term mortality in patients with severe hypercholesterolemia phenotype from a racial and ethnically diverse US cohort","volume":"149","author":"Miles","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2026.120650_bib53","first-page":"1","article-title":"Sex differences in treatment of familial hypercholesterolaemia: a meta-analysis","author":"Iatan","year":"2024","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120650_bib54","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0091-7435(03)00110-5","article-title":"The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis","volume":"37","author":"Maeda","year":"2003","journal-title":"Prev Med"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120650_bib55","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/jgs.14514","article-title":"Weight loss interventions in older adults with obesity: a systematic review of randomized controlled trials since 2005","volume":"65","author":"Batsis","year":"2017","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120650_bib56","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jacl.2018.09.008","article-title":"Diabetes is associated with an increased risk of cardiovascular disease in patients with familial hypercholesterolemia","volume":"13","author":"Paquette","year":"2019","journal-title":"J Clin Lipidol"},{"issue":"10312","key":"10.1016\/j.atherosclerosis.2026.120650_bib57","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(21)01122-3","article-title":"Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)","volume":"398","author":"Vallejo-Vaz","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2026.120650_bib58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijcard.2015.07.107","article-title":"Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: the SAFEHEART study","volume":"201","author":"Fuentes","year":"2015","journal-title":"Int J Cardiol"},{"issue":"32","key":"10.1016\/j.atherosclerosis.2026.120650_bib59","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper fromthe Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120650_bib60","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S2213-8587(19)30264-5","article-title":"Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement","volume":"8","author":"Hegele","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120650_bib61","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.ijcard.2013.06.069","article-title":"The extended abnormalities in lipoprotein metabolism in familial hypercholesterolemia: developing a new framework for future therapies","volume":"168","author":"Ooi","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120650_bib62","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.addr.2020.10.006","article-title":"Interaction between high-density lipoproteins and inflammation: function matters more than concentration","volume":"159","author":"Nazir","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2026.120650_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147856","article-title":"High-density lipoprotein subclasses and their role in the prevention and treatment of cardiovascular disease: a narrative review","volume":"25","author":"Chen","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.atherosclerosis.2026.120650_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.117507","article-title":"Gene expression profiling in elderly patients with familial hypercholesterolemia with and without coronary heart disease","volume":"392","author":"Melnes","year":"2024","journal-title":"Atherosclerosis"},{"issue":"19","key":"10.1016\/j.atherosclerosis.2026.120650_bib65","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2014.01.063","article-title":"Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation","volume":"63","author":"Alonso","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.atherosclerosis.2026.120650_bib66","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1093\/eurheartj\/ehaa1066","article-title":"Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemia","volume":"42","author":"P\u00e9rez De Isla","year":"2021","journal-title":"Eur Heart J"},{"issue":"39","key":"10.1016\/j.atherosclerosis.2026.120650_bib67","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur Heart J"},{"issue":"47","key":"10.1016\/j.atherosclerosis.2026.120650_bib68","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: Metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120650_bib69","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/jama.2018.20045","article-title":"Association of triglyceride-lowering LPL variants and LDL-C-Lowering LDLR variants with risk of coronary heart disease","volume":"321","author":"Ference","year":"2019","journal-title":"JAMA, J Am Med Assoc"},{"issue":"45","key":"10.1016\/j.atherosclerosis.2026.120650_bib70","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.atherosclerosis.2026.120650_bib71","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1161\/CIRCULATIONAHA.122.062557","article-title":"Alirocumab and coronary atherosclerosis in asymptomatic patients with familial hypercholesterolemia: the ARCHITECT study","volume":"147","author":"P\u00e9rez De Isla","year":"2023","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120650_bib72","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jcmg.2023.02.002","article-title":"Advances in coronary computed tomographic angiographic imaging of atherosclerosis for risk stratification and preventive care","volume":"16","author":"Bienstock","year":"2023","journal-title":"JACC, Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120650_bib73","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jcmg.2022.06.018","article-title":"Major Global Coronary Artery Calcium Guidelines","volume":"16","author":"Golub","year":"2023","journal-title":"JACC, Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120650_bib74","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/joim.13176","article-title":"Coronary artery calcium scoring: an evidence-based guide for primary care physicians","volume":"289","author":"Cheong","year":"2021","journal-title":"J Intern Med"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120650_bib75","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.tcm.2020.03.004","article-title":"Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levels","volume":"31","author":"Bianconi","year":"2021","journal-title":"Trends Cardiovasc Med"},{"issue":"25","key":"10.1016\/j.atherosclerosis.2026.120650_bib76","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","author":"Cardiovascular","year":"2021","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120650_bib77","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/01.CIR.34.4.553","article-title":"The Framingham study. An epidemiological approach to coronary heart disease","volume":"34","author":"Dawber","year":"1966","journal-title":"Circulation"},{"issue":"June","key":"10.1016\/j.atherosclerosis.2026.120650_bib78","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.atherosclerosis.2020.06.011","article-title":"SAFEHEART risk-equation and cholesterol-year-score are powerful predictors of cardiovascular events in French patients with familial hypercholesterolemia","volume":"306","author":"Gallo","year":"2020","journal-title":"Atherosclerosis"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191502600016X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191502600016X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:43:36Z","timestamp":1779252216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191502600016X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":78,"alternative-id":["S002191502600016X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120650","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolemia: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120650","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120650"}}